Pharmaceutical

BELLUS Health announced it will host a “Key Opinion Leader” event focused on the treatment of a chronic cough and present an update on their drug candidate.

BELLUS Health (TSX:BLU) announced it will host a “Key Opinion Leader” event focused on the treatment of a chronic cough and present an update on their drug candidate.
As quoted in the press release:

The event will feature a presentation by KOL Dr. Jacky Smith, Professor of Respiratory Medicine at the University of Manchester and Director of the NIHR South Manchester Respiratory and Allergy Clinical Research Facility. Dr. Smith will discuss the clinical presentation of chronic cough, its current unmet medical need and therapeutic options as well as novel treatment approaches under development.
Dr. Denis Garceau, BELLUS Health’s Senior Vice President, Drug Development, will also provide an update on BLU-5937, including results from preclinical studies and its development path.

Click here to read the full press release.

Source: www.newswire.ca

MARKETS

Markets
TSX20179.81+187.93
TSXV680.49+7.47
DOW33761.05+424.38
S&P 5004280.15+72.88
NASD13047.19+267.27
ASX7032.50-38.50

COMMODITIES

Commodities
Gold1801.89+0.36
Silver20.82+0.02
Copper3.68-0.03
Palladium2224.19+14.20
Platinum965.47+2.48
Oil91.88-2.46
Heating Oil3.51+0.03
Natural Gas8.78-0.09

DOWNLOAD FREE REPORTS

×